Cargando…
Comparing medication adherence in patients receiving bisphosphonates for preventing fragility fractures: a comprehensive systematic review and network meta-analysis
BACKGROUND: Bisphosphonates are effective in preventing fragility fractures; however, high rates of adherence are needed to preserve clinical benefits. OBJECTIVE: To investigate persistence and compliance to oral and intravenous bisphosphonates (alendronate, ibandronate, risedronate, and zoledronate...
Autores principales: | Bastounis, A., Langley, T., Davis, S., Paskins, Z., Gittoes, N., Leonardi-Bee, J., Sahota, O. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer London
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9106630/ https://www.ncbi.nlm.nih.gov/pubmed/35188591 http://dx.doi.org/10.1007/s00198-022-06350-w |
Ejemplares similares
-
Assessing the Effectiveness of Bisphosphonates for the Prevention of Fragility Fractures: An Updated Systematic Review and Network Meta‐Analyses
por: Bastounis, Anastasios, et al.
Publicado: (2022) -
Clinicians’ views of prescribing oral and intravenous bisphosphonates for osteoporosis: a qualitative study
por: Bishop, Simon, et al.
Publicado: (2023) -
Acceptability of bisphosphonates among patients, clinicians and managers: a systematic review and framework synthesis
por: Paskins, Zoe, et al.
Publicado: (2020) -
Incidence and predictors of fragility fracture in postmenopausal rheumatoid arthritis patients receiving oral bisphosphonates: a longitudinal observational study
por: Kishimoto, Yuji, et al.
Publicado: (2022) -
Understanding fragility fracture patients’ decision-making process regarding bisphosphonate treatment
por: Wozniak, L. A., et al.
Publicado: (2016)